Functionalized Macrophage Exosomes with Panobinostat and PPM1D-siRNA for Diffuse Intrinsic Pontine Gliomas Therapy

Area of Science:

• Oncology
• Nanomedicine
• Gene Therapy

Background:

• Diffuse intrinsic pontine glioma (DIPG) is a fatal pediatric brain tumor often associated with p53-induced protein phosphatase 1 (PPM1D) mutations.
• PPM1D mutations drive DIPG proliferation, making PPM1D inhibition a potential therapeutic strategy.
• Panobinostat shows efficacy against DIPG cells but faces limitations due to systemic toxicity and poor blood-brain barrier (BBB) penetration.

Purpose of the Study:

• To develop a targeted nano drug delivery system for DIPG with PPM1D mutations.
• To co-deliver panobinostat and PPM1D-siRNA using functionalized macrophage exosomes.
• To evaluate the efficacy and BBB penetration of the novel nanodelivery system in vitro and in vivo.

Main Methods:

• Preparation of macrophage exosome-based nanocarriers functionalized for targeted delivery.
• Encapsulation of panobinostat (small molecule drug) and PPM1D-siRNA (gene drug) within the exosomes.
• In vitro and in vivo experiments to assess drug delivery efficiency, BBB crossing, tumor cell targeting, and therapeutic efficacy in DIPG models.

Main Results:

• The exosome-based nanodelivery system demonstrated enhanced drug delivery efficiency compared to free drugs.
• Successful delivery of panobinostat and PPM1D-siRNA across the BBB was achieved.
• Targeted killing of DIPG tumor cells and prolonged survival of orthotopic DIPG mice were observed.

Conclusions:

• Functionalized macrophage exosomes serve as an effective nano drug delivery system for co-delivering small molecule and gene drugs to DIPG.
• This approach overcomes BBB penetration limitations and enhances therapeutic outcomes for DIPG with PPM1D mutations.
• The study offers a promising strategy for targeted DIPG therapy, advancing small molecule and gene drug delivery.